Publications
212
Citations
9,503
Est. group size
—
Recurring co-author estimate
Active years
60
Publishing since 1967
Aristide Merola's research focuses on movement disorders, especially Parkinson's disease, with particular attention to deep brain stimulation (DBS) technologies, gene therapy approaches like AAV2-GDNF, and device-based treatments for advanced disease. Work also spans related clinical areas such as autonomic dysfunction, tremor diagnosis using smartphones/machine learning, and cost-effectiveness or comparative-effectiveness studies of therapies for Parkinson's disease and treatment-resistant depression. Students would encounter a mix of clinical trials, technology evaluation, and health economics research within neurology.
Publication output was relatively steady to declining over the past decade, dropping from around 20 papers per year in 2017 to a handful of papers annually in the most recent years (2023-2026).
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Phase 2 Clinical Trial of MK-1942, a Negative Allosteric Modulator of Metabotropic Glutamate Receptor 2, for Treatment-Resistant Depression
Journal of Clinical Psychopharmacology · 2026
- Association and risk prediction of 19 complex diseases with polygenic scores and socioeconomic status
Communications Medicine · 2026
- Intraputaminal Delivery of Adeno‐Associated Virus Serotype 2<b>–</b>Glial Cell Line–Derived Neurotrophic Factor in Mild or Moderate Parkinson's Disease
Movement Disorders · 2025
- Trajectories of pharmacological therapies for treatment-resistant depression: a longitudinal study
BMC Psychiatry · 2025
- Sodium-glucose cotransporter 2 inhibitor dapagliflozin prevents ejection fraction reduction, reduces myocardial and renal NF-κB expression and systemic pro-inflammatory biomarkers in models of short-term doxorubicin cardiotoxicity
Frontiers in Cardiovascular Medicine · 2024
- Phase 1b Safety and Preliminary Efficacy of Bilateral Intraputaminal Delivery of AAV2 GDNF (AB-1005) in Participants With Mild or Moderate Parkinson’s Disease (N2.001)
Neurology · 2024
- AAV2-GDNF Gene Delivery in Mild- and Moderate-Stages of Parkinson’s Disease: Preliminary Brain Imaging and Clinical Outcomes
Parkinsonism & Related Disorders · 2024
- Retraction Note: Pallidal deep brain stimulation for tardive dystonia: meta-analysis of clinical outcomes
Neurological Sciences · 2024
- Automated Motion Sensor‐Based Functional Mapping Improves Deep Brain Stimulation Programming Efficiency
Movement Disorders Clinical Practice · 2024
- Real-World Outcomes in USA using DBS Systems with Directionality and Multiple Independent Current Control (P5-11.017)
Neurology · 2023
- Cost‐Effectiveness of Carbidopa‐Levodopa Enteral Suspension for Advanced Parkinson's Disease in the United States
Movement Disorders · 2023
- Hope vs. Hype: Closed loop technology will provide more meaningful improvement vs. directional leads in deep brain stimulation
Parkinsonism & Related Disorders · 2023
- ID: 197975 Real-World Outcomes Using DBS Systems With Directionality and Multiple Independent Current Control: USA Experience
Neuromodulation Technology at the Neural Interface · 2023
- Necessity and feasibility of remote tele-programming of deep brain stimulation systems in Parkinson’s disease
Parkinsonism & Related Disorders · 2023
- Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson’s Disease: A Systematic Review and Bayesian Network Meta-analysis
CNS Drugs · 2022
- Parkinsonism & Related Disorders×16
- Movement Disorders×15
- Journal of Neurology×14
- Neurology×9
- Movement Disorders Clinical Practice×6
- Ariane Park
Medicine · The Ohio State University
- Lijuan Wang
Medicine · The Ohio State University
- Carson Reider
Medicine · The Ohio State University
- Allison J. Schaser
Medicine · Purdue University West Lafayette
- Aswathy Chandran
Medicine · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile